Lipotec, S.a.

Lubrizol Advanced Materials, Inc.

Nuria Garcia Sanz

Nuria Almiñana Domenech

Antonio Vicente Ferrer Montiel

Cristina Carreño Serraïma

Wim Van Den Nest

Juan Cebrián Puche

Albert Soley Astals

Antonio Ferrer Montiel

Gregorio Joaquin Fernandez Ballester

Olga Laporta Alcantara

Juan Cebri{dot Over (a)}n Puche

Cristina Carreno Serraiema

Katalina Rodriguez Bielsa

Olga Laporta

Nuria ALMIÑANA DOMÈNECH

A method of treatment and/or care of the skin includes administering a composition which includes a cosmetically or dermopharmaceutically effective quantity (between 0.000001% by weight and 5% by weight of the composition) of an exopolysaccharide produced by a strain of, or a ferment extract comprising the exopolysaccharide. The exopolysaccharide has a composition by weight of 0.5% to 45% of rhamnose, 0.1% to 25% of galactose, 0.5% to 30% of mannose, 50% to 95% for the sum of glucose and D-glucosamine, 0% to 10% of fucose and 0% to 12% of glucuronic acid, with the condition that the sum of the percentages does not exceed 100%.

Cosmetic composition containing halomonas ferment extract, and use thereof

Peptides of general formula (I): RAA-AA-AA-AA-Rstereoisomers thereof, mixtures thereof or the cosmetically or pharmaceutically acceptable salts thereof, a method for obtaining them, cosmetic or pharmaceutical compositions containing them, and their use for the treatment and/or care of those conditions, disorders and/or pathologies of the skin, mucosae and/or scalp resulting from matrix metalloproteinases (MMP) overexpression or an increase in the MMP activity.

Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors

Peptides of general formula (I): R-W-X-AA-AA-AA-AA-AA-AA-Y-Z-Rtheir stereoisomers, mixtures thereof and/or their cosmetically or pharmaceutically acceptable salts, their preparation process, cosmetic or pharmaceutical compositions which contain them and their use in the treatment and/or care of conditions, disorders and/or diseases that are a consequence of muscle contraction.

Peptide-based compounds and compositions which inhibit muscle contraction

Peptides of general formula (I): R-W-X-AA1-AA-AA-AA-Y-Rtheir stereoisomers, mixtures thereof, and/or their cosmetically or pharmaceutically acceptable salts, a method of preparation, cosmetic or pharmaceutical compositions containing them and their use for the treatment, prevention and/or care of conditions, disorders and/or diseases of the skin, mucous membranes and/or scalp.

Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp

Growing community of inventors

Alicante, Spain

Nuria Garcia Sanz